Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal

Circulation

Volumn 97, Issue 11, 1998, Pages 1071-1078

  Ruef, Johannes ^a   Rao, Gadiparthi N ^a   Li, Fengzhi ^a   Bode, Christoph ^b   Patterson, Cam ^a   Bhatnagar, Aruni ^a   Runge, Marschall S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Atherosclerosis; Lipids; Mitogens; Oxidation; Signal transduction

Indexed keywords

4 HYDROXYNONENAL; ACETYLCYSTEINE; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR AA; PROTEIN C FOS; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL COUNT; CELL GROWTH; DNA BINDING; DNA PROTEIN COMPLEX; DNA SYNTHESIS; LIPID PEROXIDATION; MALE; MITOGENESIS; NONHUMAN; ONCOGENE C FOS; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER;

ALDEHYDES; ANIMALS; AORTA; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; LIPID PEROXIDATION; MALE; MITOSIS; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 0032562272     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.11.1071     Document Type: Article

References (70)

1. Steinberg D. Antioxidants and atherosclerosis: a current assessment. Circulation. 1991;84:1420-1425.
2. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994;344: 793-795.
3. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995;57: 791-804.
4. Babior BM. Oxidants from phagocytes: agents of defense and destruction. Blood. 1984;64:959-966.
5. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
6. Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Atherosclerosis. 1984;4:357-364.
7. Stringer MD, Görög PG, Freeman A, Kakkar VV. Lipid peroxides and atherosclerosis. BMJ. 1989;298:281-284.
8. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res. 1992;70: 593-599.
9. Rao GN, Lasségue B, Griendling KK, Alexander RW. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid. Oncogene. 1993;8:2759-2764.
10. Rao GN, Lasségue B, Griendling KK, Alexander RW, Berk BC. Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: role of protein kinase C. Nucleic Acids Res. 1993;21: 1259-1263.
11. Rao GN, Alexander RW, Runge MS. Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-fos, c-jun, and c-myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells. J Clin Invest. 1995;96:842-847.
12. Rao GN, Glasgow WC, Eling TE, Runge MS. Role of hydroperoxyeicosatetraenoic acids in oxidative stress-induced protein (AP-1) activity. J Biol Chem. 1996;271:27760-27764.
13. 2 for platelet-derived growth factor signal transduction. Science. 1995;270:296-299.
14. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A. 1987;84:7725-7729.
15. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr. 1991;52:3265-3345.
16. Gaziano JM, Hennekens CH. The role of beta-carotene in the prevention of cardiovascular disease. In: Canfield LM, Krinsky NI, Olson JA, eds. Carotenoids in Human Health. New York, NY: New York Academy of Sciences; 1993:148-155.
17. Tsai J-C, Jain M, Hsieh C-M, Lee W-S, Yoshizumi M, Patterson C, Perrella MA, Cooke C, Wang H, Haber E, Schlegel R, Lee M-E. Induction of apoptosis by pyrrolidinedithiocarbamate and n-acetylcysteine in vascular smooth muscle cells. J Biol Chem. 1996;271:3667-3670.
18. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20:707-727.
19. Natarajan V, Scribner WM, Hart CM, Parthasarathy S. Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis. J Lipid Res. 1995;36:2005-2016.
20. Esterbauer H, Zollner H. Methods for determination of aldehydic lipid peroxidation products. Free Radic Biol Med. 1989;7:197-203.
21. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med. 1991; 11: 81-128.
22. Strohmaier H, Hinghofer-Szalkay H, Schaur RJ. Detection of 4-hydroxynonenal (HNE) as a physiological component in human plasma. J Lipid Med. 1995;11:51-61.
23. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
24. Jürgens G, Chen Q, Esterbauer H, Mair S, Ledinski G, Dinges HP. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). Arterioscler Thromb. 1993;13: 1689-1699.
25. Ruef J, Hu Z, Yin L-Y, Wu Y, Hanson SR, Kelly AB, Harker LA, Rao GN, Runge MS, Patterson C. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. Circ Res. 1997;81:24-33.
26. Schaur RJ, Dussing G, Kink E, Schauenstein E, Posch W, Kukovetz E, Egger G. The lipid peroxidation product 4-hydroxynonenal is formed by and is able to attract rat neutrophils in vivo. Free Radic Res Commun. 1994;20:365-373.
27. Rossi MA, DiMauro C, Dianzani MU. Action of lipid peroxidation products on phosphoinositide specific phospholipase C. Mol Aspects Med. 1993;14:273-279.
28. Zarkovic N, Ilic Z, Jurin M, Schaur RJ, Puhl H, Esterbauer H. Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funct. 1993;11:279-286.
29. Nolan MR, Kennedy S, Blanchflower WJ, Kennedy DG. Lipid peroxidation, prostacyclin and thromboxane A2 in pigs depleted of Vitamin E and selenium and supplemented with linseed oil. Br J Nutr. 1995;74:369-380.
30. Blasig IE, Grune, T, Schonheit K, Rohde E, Jakstadt M, Haseloff RF, Siems WG. 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium. Am J Physiol 1995;269:H14-H22.
31. Yontaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adduces in Parkinson's disease. Proc Natl Acad Sci U S A. 1996;93:2696-2701.
32. Travo P, Barret G, Burnstock G. Differences in proliferation of primary cultures of vascular smooth muscle cells taken from male and female rats. Blood Vessels. 1980;17:110-116.
33. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
34. Bennett MR, Evan GI, Schwartz SM. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ Res. 1995;77:206-272.
35. Kameshita I, Fujisawa H. A sensitive method for detection of calmodulin-dependent protein kinase-II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal Biochem. 1989;183:139-143.
36. Rao GN. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases of mitogen-activated protein kinases. Oncogene. 1996;13:713-719.
37. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475-1489.
38. Russo A, DeGraff W, Friedman N, Mitchell JB. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res. 1986;46: 2845-2848.
39. Weiner LM, Hu H, Swartz HM. EPR method for the measurement of cellular sulfhydryl groups. FEBS Lett. 1991;290:243-246.
40. Hwang DL, Latus LJ, Lev-Ran A. Effects of platelet-contained growth factors (PDGF, EGF, IGF-1, and TGF-beta) on DNA synthesis in porcine aortic smooth muscle cells in culture. Exp Cell Res. 1992;200:358-360.
41. Fazio VM, Rinaldi M, Ciafré S, Barrera G, Farace MG. Control of neoplastic cell proliferation and differentiation by restoration of 4-hydroxynonenal physiological concentrations. Mol Aspects Med. 1993;14: 217-228.
42. - in vascular smooth muscle cells. Circ Res. 1995; 77:29-36.
43. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1992;188:257-264.
44. Davis JR. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993;268:14553-14556.
45. Sen CK, L Packer. Antioxidant and redox regulation of gene transcription. FASEB J. 1996;10:709-720.
46. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem. 1991;266:8604-8608.
47. Bergelson S, Pinkus R, Daniel V. Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression. Cancer Res. 1994;54:36-40.
48. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science. 1989;243: 393-396.
49. Stouffer GA, Sarembock IJ, Mc Namara CA, Gimple LW, Owens GK. Thrombin-induced mitogenesis of vascular SMC is partially mediated by autocrine production of PDGF-AA. Am J Physiol 1993;265:C806-C811.
50. Brattin WJ, Glende EA Jr, Recknagel RO. Pathological mechanisms in carbon tetrachloride hepatotoxicity. J Free Radic Biol Med. 1985;1:27-38.
51. 2: role in cell survival following oxidant injury. J Biol Chem. 1996;271:4138-4142.
52. Augé N, Pieraggi MT, Thiers JC, Negre-Salvayre A, Salvayre R. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J. 1995;309:1015-1020.
53. Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest. 1995;96:2322-2330.
54. Nadkarni DV, Sayre LM. Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem Res Toxicol. 1995;8: 284-291.
55. Chai YC, Howe PH, DiCorleto PE, Chisolm GM. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. J Biol Chem. 1996;271:17791-17797.
56. Stiko-Rahm A, Hultg;ardh-Nilsson A, Regnström J, Hamsten A, Nilsson LJ. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler Thromb. 1992;12:1099-1109.
57. Dianzani MU. Lipid peroxidation and cancer. Crit Rev Oncol Hematol. 1993;15:125-147.
58. Benedetti A, Comporti M, Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta. 1980;620:281-296.
59. Jürgens G, Lang J, Esterbauer H. Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochim Biophys Acta. 1986;875:103-114.
60. Uchida K, Toyokuni S, Nishikawa K, Kawakishi S, Oda H, Hiai H, Stadtman ER. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry. 1994;33:12487-12494.
61. Dogterom P, Mulder GJ, Nagelkerke JF. Lipid peroxidation-dependent and -independent protein thiol modifications in isolated rat hepatocytes: differential effects of vitamin E and disulfiram. Chem Biol Interact. 1989;71: 291-306.
62. Spitz DR, Sullivan SJ, Malcolm RR, Roberts RL. Glutathione dependent metabolism and detoxification of 4-hydroxy-2-nonenal. Free Radic Biol Med. 1991;11:415-423.
63. Lander HM, Jacovina AT, Davis RJ, Tauras JM. Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J Biol Chem. 1996;271:19705-19709.
64. Fialkow L, Chan CK, Rotin D, Grinstein S, Downey GP. Activation of the mitogen-activated protein kinase signaling pathway in neutrophils: role of oxidants. J Biol Chem. 1994;269:31234-31242.
65. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 1996;10:709-720.
66. Tessitore L, Matera L, Bonelli G, Baccino FM, Dianzani MU. Aliphatic aldehydes inhibit the proliferative response of human peripheral blood lymphocytes to phytohemagglutinin and alloantigens. Chem Biol Interact Med. 1987;4:377-386.
67. 6-methylguanine DNA methyltransferase by various aldehydes in cultured human bronchial fibroblasts. Carcinogenesis. 1985;6: 1755-1759.
68. Nishikawa A, Sodum R, Chung FL. Acute toxicity of trans-5-hydroxy-2-nonenal in fisher 344 rats. Lipids. 1992;27:54-58.
69. Chatterjee S. Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation. Mol Cell Biochem. 1992;111:143-147.
70. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. Circulation. 1996;94:2013-2020.